Go Pro

Sabra Healthcare REIT (SBRA) Competitors

Sabra Healthcare REIT logo
$20.52 -0.31 (-1.49%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$20.52 0.00 (0.00%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBRA vs. CTRE, LTC, NHI, OHI, and VTR

Should you buy Sabra Healthcare REIT stock or one of its competitors? Sabra Healthcare REIT's main competitors and comparable companies include CareTrust REIT (CTRE), LTC Properties (LTC), National Health Investors (NHI), Omega Healthcare Investors (OHI), and Ventas (VTR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare reits" industry.

How does Sabra Healthcare REIT compare to CareTrust REIT?

CareTrust REIT (NYSE:CTRE) and Sabra Healthcare REIT (NASDAQ:SBRA) are both mid-cap real estate companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

CareTrust REIT has a net margin of 62.19% compared to Sabra Healthcare REIT's net margin of 7.61%. CareTrust REIT's return on equity of 8.52% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
CareTrust REIT62.19% 8.52% 6.64%
Sabra Healthcare REIT 7.61%2.34%1.18%

CareTrust REIT has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

CareTrust REIT currently has a consensus target price of $44.50, suggesting a potential upside of 15.16%. Sabra Healthcare REIT has a consensus target price of $22.23, suggesting a potential upside of 8.34%. Given CareTrust REIT's stronger consensus rating and higher possible upside, equities analysts plainly believe CareTrust REIT is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareTrust REIT
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.0%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.8%. CareTrust REIT pays out 98.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CareTrust REIT has increased its dividend for 3 consecutive years.

87.8% of CareTrust REIT shares are owned by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are owned by institutional investors. 0.7% of CareTrust REIT shares are owned by company insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CareTrust REIT has higher earnings, but lower revenue than Sabra Healthcare REIT. CareTrust REIT is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareTrust REIT$452.64M20.17$320.54M$1.5924.30
Sabra Healthcare REIT$774.63M6.77$155.61M$0.2678.92

In the previous week, Sabra Healthcare REIT had 7 more articles in the media than CareTrust REIT. MarketBeat recorded 15 mentions for Sabra Healthcare REIT and 8 mentions for CareTrust REIT. CareTrust REIT's average media sentiment score of 1.07 beat Sabra Healthcare REIT's score of 1.03 indicating that CareTrust REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareTrust REIT
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sabra Healthcare REIT
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CareTrust REIT beats Sabra Healthcare REIT on 14 of the 20 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to LTC Properties?

Sabra Healthcare REIT (NASDAQ:SBRA) and LTC Properties (NYSE:LTC) are both mid-cap real estate companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Sabra Healthcare REIT has higher revenue and earnings than LTC Properties. LTC Properties is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.77$155.61M$0.2678.92
LTC Properties$347.85M6.56$117.97M$2.7115.62

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.8%. LTC Properties pays an annual dividend of $2.28 per share and has a dividend yield of 5.4%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. LTC Properties pays out 84.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Sabra Healthcare REIT currently has a consensus price target of $22.23, indicating a potential upside of 8.34%. LTC Properties has a consensus price target of $44.43, indicating a potential upside of 4.98%. Given Sabra Healthcare REIT's higher possible upside, equities analysts plainly believe Sabra Healthcare REIT is more favorable than LTC Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50
LTC Properties
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

Sabra Healthcare REIT has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market. Comparatively, LTC Properties has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

LTC Properties has a net margin of 38.84% compared to Sabra Healthcare REIT's net margin of 7.61%. LTC Properties' return on equity of 11.42% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT7.61% 2.34% 1.18%
LTC Properties 38.84%11.42%6.45%

99.4% of Sabra Healthcare REIT shares are held by institutional investors. Comparatively, 69.3% of LTC Properties shares are held by institutional investors. 1.1% of Sabra Healthcare REIT shares are held by company insiders. Comparatively, 2.2% of LTC Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Sabra Healthcare REIT had 6 more articles in the media than LTC Properties. MarketBeat recorded 15 mentions for Sabra Healthcare REIT and 9 mentions for LTC Properties. Sabra Healthcare REIT's average media sentiment score of 1.03 beat LTC Properties' score of 0.98 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LTC Properties
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Sabra Healthcare REIT beats LTC Properties on 11 of the 18 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to National Health Investors?

Sabra Healthcare REIT (NASDAQ:SBRA) and National Health Investors (NYSE:NHI) are both mid-cap real estate companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Sabra Healthcare REIT has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market. Comparatively, National Health Investors has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market.

Sabra Healthcare REIT presently has a consensus target price of $22.23, suggesting a potential upside of 8.34%. National Health Investors has a consensus target price of $82.25, suggesting a potential upside of 16.78%. Given National Health Investors' stronger consensus rating and higher probable upside, analysts plainly believe National Health Investors is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50
National Health Investors
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.56

99.4% of Sabra Healthcare REIT shares are held by institutional investors. Comparatively, 62.5% of National Health Investors shares are held by institutional investors. 1.1% of Sabra Healthcare REIT shares are held by insiders. Comparatively, 2.7% of National Health Investors shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.8%. National Health Investors pays an annual dividend of $3.68 per share and has a dividend yield of 5.2%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. National Health Investors pays out 106.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Sabra Healthcare REIT had 9 more articles in the media than National Health Investors. MarketBeat recorded 15 mentions for Sabra Healthcare REIT and 6 mentions for National Health Investors. National Health Investors' average media sentiment score of 1.08 beat Sabra Healthcare REIT's score of 1.03 indicating that National Health Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sabra Healthcare REIT
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Health Investors
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Sabra Healthcare REIT has higher revenue and earnings than National Health Investors. National Health Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sabra Healthcare REIT$774.63M6.77$155.61M$0.2678.92
National Health Investors$375.63M9.21$142.18M$3.4620.36

National Health Investors has a net margin of 38.56% compared to Sabra Healthcare REIT's net margin of 7.61%. National Health Investors' return on equity of 10.89% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Sabra Healthcare REIT7.61% 2.34% 1.18%
National Health Investors 38.56%10.89%5.88%

Summary

National Health Investors beats Sabra Healthcare REIT on 10 of the 18 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Omega Healthcare Investors?

Omega Healthcare Investors (NYSE:OHI) and Sabra Healthcare REIT (NASDAQ:SBRA) are both real estate companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Sabra Healthcare REIT had 10 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 15 mentions for Sabra Healthcare REIT and 5 mentions for Omega Healthcare Investors. Omega Healthcare Investors' average media sentiment score of 1.42 beat Sabra Healthcare REIT's score of 1.03 indicating that Omega Healthcare Investors is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omega Healthcare Investors
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sabra Healthcare REIT
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Omega Healthcare Investors has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

Omega Healthcare Investors has higher revenue and earnings than Sabra Healthcare REIT. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Healthcare Investors$1.28B11.10$572.03M$2.8016.78
Sabra Healthcare REIT$774.63M6.77$155.61M$0.2678.92

Omega Healthcare Investors currently has a consensus price target of $49.50, indicating a potential upside of 5.39%. Sabra Healthcare REIT has a consensus price target of $22.23, indicating a potential upside of 8.34%. Given Sabra Healthcare REIT's stronger consensus rating and higher probable upside, analysts clearly believe Sabra Healthcare REIT is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Healthcare Investors
2 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.27
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Omega Healthcare Investors has a net margin of 66.96% compared to Sabra Healthcare REIT's net margin of 7.61%. Omega Healthcare Investors' return on equity of 15.76% beat Sabra Healthcare REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Healthcare Investors66.96% 15.76% 8.40%
Sabra Healthcare REIT 7.61%2.34%1.18%

Omega Healthcare Investors pays an annual dividend of $2.72 per share and has a dividend yield of 5.8%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.8%. Omega Healthcare Investors pays out 97.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

65.3% of Omega Healthcare Investors shares are owned by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are owned by institutional investors. 1.7% of Omega Healthcare Investors shares are owned by insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Omega Healthcare Investors beats Sabra Healthcare REIT on 10 of the 18 factors compared between the two stocks.

How does Sabra Healthcare REIT compare to Ventas?

Ventas (NYSE:VTR) and Sabra Healthcare REIT (NASDAQ:SBRA) are both real estate companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.

Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.3%. Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.8%. Ventas pays out 385.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has increased its dividend for 1 consecutive years.

94.2% of Ventas shares are held by institutional investors. Comparatively, 99.4% of Sabra Healthcare REIT shares are held by institutional investors. 0.5% of Ventas shares are held by insiders. Comparatively, 1.1% of Sabra Healthcare REIT shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ventas currently has a consensus target price of $99.00, suggesting a potential upside of 9.88%. Sabra Healthcare REIT has a consensus target price of $22.23, suggesting a potential upside of 8.34%. Given Ventas' stronger consensus rating and higher possible upside, research analysts clearly believe Ventas is more favorable than Sabra Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventas
0 Sell rating(s)
3 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.82
Sabra Healthcare REIT
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Ventas has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Sabra Healthcare REIT has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market.

Sabra Healthcare REIT has a net margin of 7.61% compared to Ventas' net margin of 4.08%. Sabra Healthcare REIT's return on equity of 2.34% beat Ventas' return on equity.

Company Net Margins Return on Equity Return on Assets
Ventas4.08% 1.99% 0.94%
Sabra Healthcare REIT 7.61%2.34%1.18%

Ventas has higher revenue and earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventas$6.44B7.17$251.38M$0.54166.85
Sabra Healthcare REIT$774.63M6.77$155.61M$0.2678.92

In the previous week, Sabra Healthcare REIT had 3 more articles in the media than Ventas. MarketBeat recorded 15 mentions for Sabra Healthcare REIT and 12 mentions for Ventas. Ventas' average media sentiment score of 1.38 beat Sabra Healthcare REIT's score of 1.03 indicating that Ventas is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ventas
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sabra Healthcare REIT
8 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Ventas beats Sabra Healthcare REIT on 12 of the 19 factors compared between the two stocks.

Get Sabra Healthcare REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBRA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBRA vs. The Competition

MetricSabra Healthcare REITHealthcare REITs IndustryReal Estate SectorNASDAQ Exchange
Market Cap$5.32B$12.54B$5.45B$12.72B
Dividend Yield5.76%5.64%6.46%11.15%
P/E Ratio78.9360.3628.2825.29
Price / Sales6.77108.26124.8998.94
Price / Cash15.1624.2834.3351.44
Price / Book1.811.781.826.20
Net Income$155.61M-$1.49M-$64.10M$358.50M
7 Day Performance-1.25%-1.10%-1.55%-2.35%
1 Month Performance1.63%-0.33%-3.18%-2.77%
1 Year Performance7.72%11.84%-0.82%7.63%

Sabra Healthcare REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBRA
Sabra Healthcare REIT
3.0457 of 5 stars
$20.52
-1.5%
$22.23
+8.3%
+7.3%$5.32B$774.63M78.9358
CTRE
CareTrust REIT
4.4746 of 5 stars
$39.06
+0.1%
$44.55
+14.0%
+13.0%$9.22B$476.39M24.5720
LTC
LTC Properties
3.9219 of 5 stars
$41.29
+0.2%
$44.00
+6.6%
+15.8%$2.22B$262.85M15.2420
NHI
National Health Investors
4.4531 of 5 stars
$70.90
+0.0%
$83.57
+17.9%
-11.0%$3.48B$375.63M20.4920
OHI
Omega Healthcare Investors
3.0997 of 5 stars
$46.41
+0.1%
$49.50
+6.7%
+10.6%$14.05B$1.19B16.5850

Related Companies and Tools


This page (NASDAQ:SBRA) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners